ANGPT2 and neoplasm: Consistently, a study demonstrated that ANG2 inhibition combined with chemotherapy suppresses metastatic growth by limiting the recruitment of tumor-promoting macrophages in the postsurgical adjuvant setting as well as in a preclinical anti-VEGF-refractory tumor model [67].